Policy/Enforcement News
NABP Warns: Fake Online Pharmacy Collective Pretends to Be Canadian Pharmacies
The new NABP report warns that a fake online pharmacy collective is posing as individual, but fake, Canadian pharmacies. In their latest quarterly report, the National Association of Boards of Pharmacy calls for strong consumer outreach in response to ever-more sophisticated efforts by fake online pharmacies in disguising the illegal nature of their operations. The July progress report from…
[...]Pangea VI International Enforcement Operation Shuts Down 9,600 Fake Online Pharmacies
Interpol-coordinated global operation targeted fake online pharmacy trade, netted over $41 million worth of counterfeit medication, and shut down more than 9,600 fake online pharmacies. Fake versions of drugs used to treat diabetes symptoms, arthritis, and schizophrenia were seized as part of the operation. 58 arrests have been made. On June 27, 2013, Interpol announced…
[...]Two Men Extradited for Running Fake Online Pharmacy From UK and Pakistan
Two Pakistani nationals have been extradited to the United States for their alleged role in importing misbranded pharmaceuticals and controlled substances worth approximately $780,000 into the United Sates by offering them for sale via the Internet. The drugs were packaged and shipped from locations in the United Kingdom as well as Pakistan.
The U.S. Department of Justice (DOJ) released a report May 20th on the extradition and arrest of Sheikh Waseem Ul Haq, and Tahir Saeed of Karachi, Pakistan. The two men are charged with “conspiracy to import controlled substance pharmaceuticals into the United States; conspiracy to distribute controlled substance pharmaceuticals; conspiracy to introduce misbranded pharmaceuticals into interstate commerce; importation and distribution of controlled substance pharmaceuticals; introduction into interstate commerce of misbranded drugs, and conspiracy to commit international money laundering. It also includes a forfeiture allegation seeking all proceeds that can be traced to the scheme.”
[...]How To Save Money Safely On Medication – Buy Local, Buy Generic
The Partnership for Safe Medicines recently gained access to a RFP submission from a foreign drug broker, purporting to save money for a Maine employee union. We studied the top 30 medications purchased by this union and price-compared black market foreign pharmacies to pharmacies who possessed a pharmacy license in Maine.
Using legitimate, FDA approved generic saves more than 80% of the cost of the name-brand medication, while purchasing from the black market foreign pharmacy saves less than 50%, while exposing patients to the dangers of substandard, misbranded and counterfeit drugs.
[...]Generic Drug Maker Ranbaxy Settles with DOJ in Adulterated Drugs Case
The US Department of Justice reports that a plea agreement by the US branch of Indian generic drug giant Ranbaxy is the largest ever against a generic drug manufacture. Ranbaxy admitted to selling unapproved and adulterated prescription drugs in the United States.
According to the Department of Justice statement on this case, the drugs manufactured at two different plants in India, one in Dewas, and another in Paonta Sahib. The manufacturers failed to follow Current Good Manufacturing Practices (cGMPs) as mandated by the FDA. In many cases the drugs were not up to FDA standards and degraded much faster than their authentic counterparts. The Department of Justice also reports that Ranbaxy knowingly made false statements to the FDA as to the testing, content and quality of the drugs it sold in the United States.
[...]FDA Releases Video on Counterfeit Detection Device 3
The FDA has released more information about their new counterfeit drug detection device, Counterfeit Detection Device 3 (CD-3). In this newly-released video, Nico Ranieri, the FDA research biologist who developed this new technology talks about how important such innovations are to patient safety.
In
2005, it first occurred to Nicolas Ranieri to try to use the type of
ultra-violet light devices deployed in crime scene investigations in a
hand-held counterfeit drug detection device.
Up to that point, drug testing equipment was both delicate, expensive, and
also required highly-trained scientists to
perform the tests for fakes. Says
Ranieri, “We wanted to find counterfeits, and we wanted to find them as fast as
possible,” reports the FDA.
LD 171 and LD 449 will expose Mainers to counterfeit drugs
Two proposals in the Maine legislature (LD 171 and LD 449) to import drugs from all over the world would endanger Maine patients without saving them any money. Maine patients would end up having their prescriptions filled by foreign companies that aren’t licensed pharmacies and sell drugs that aren’t even FDA-approved, assuming they didn’t get counterfeit drugs with either chalk or toxins.
For a serious condition, such as high blood pressure, asthma, and blood clots, even medicine made of chalk is a dangerous pill.
[...]Operator of Canada Drugs Subsidiary Pleads Guilty in Counterfeit Drugs Case
When counterfeit cancer medication was found in US distribution at doctors’ offices throughout the country, the source of the fake drugs was traced to Canada Drugs affiliate, Montana Healthcare Solutions (MHS). Now the Wall Street Journal is reporting that a man who marketed the fake cancer drugs to US doctors is due to plead guilty to felony charges in the case.
On March 21, 2013, Paul Bottomley, a UK citizen and founder of Montana Healthcare Solutions, signed a plea agreement wherein he accepted his guilt for his role in the distribution of counterfeit cancer medication, reports the Wall Street Journal. According to the Plea Agreement, Bottomley waved the right to a jury trial and agreed to plead guilty to misprision of a felony, or aiding in the commission of a felony. The plea agreement also states that Bottomley “maintains he can provide substantial assistance to the United States” and in so doing, further reduce his sentence.
Bottomley had previously agreed to forfeit the proceeds of his business to the Federal Government, including land and an ostentasiously expensive Aston Martin, sold at auction for $110,000, reports the Missoulan.
Bottomley initially denied any connection to the fake Avastin distribution, telling CBS news via text that Montana Healthcare Solutions had shut down in 2010, and that he “knew nothing of this Avastin matter.” Subsequent investigations however linked him to the sale of the fake Avastin. CBS reports further that a doctor they spoke to received a price sheet in 2011 from MHS with Bottomley listed as the “Business Development Director.”
Back in February 2012 when the FDA first reported that counterfeit Avastin had been found at US doctors’ offices, they identified Montana Healthcare Solutions as one of the suppliers. At that time MHS’s links to online pharmacy giant Canada Drugs were not as yet understood. In July of 2012, the Wall Street Journal linked the two companies in print for the first time. Montana Healthcare Solutions has since been identified by the FDA as “owned and operated by Canada Drugs.”
In related news, The Winnepeg Sun is reporting that Canada Drugs has laid off hundreds of employees in the wake of the FDA’s efforts to shut down their US operations.
To learn more about the safety of purported Canadian Internet pharmacies, and to insure that your medicine stays safe read “The 5 Secrets Canadian Web Pharmacies Don’t Want You To Know.”
To learn more about the counterfeit Avastin case, and check to see if your doctor received a warning letter from the FDA about fake cancer medication, read our Update on Fake Avastin.
[...]United Nations Report on East Asian Organized Crime: Criminal Made $5 Billion in Fake Drug Profits
The United Nations Office on Drugs and Crime (UNODC) has just released their report on organized crime activities in East Asia. It shows counterfeited/ fraudulent pharmaceuticals are a growing source of profit for criminal gangs, and countries with lax enforcement are the biggest market fraudulent medicines.
[...]2 Rhode Island Men Plead Guilty in International Fake Internet Pharmacy Scheme
Rhode Island pair pleaded guilty to being part of an international criminal enterprise based in Israel that imported steroids and misbranded pharmaceuticals into the United States for sale via the Internet. The drugs were repackaged and shipped from their facility in Rhode Island.
The US Department of Justice (DOJ) reported on March 13th that two Rhode Island men, Edmond Paolucci, and Patrick Cunningham have pleaded guilty to receiving, repackaging and shipping steroids and misbranded prescription drugs to Internet customers who placed orders with the Israel-based Internet pharmacy.
[...]